Company intelligence / Profile preview

Shanghai GM BioX

Shanghai, Shanghai, China

Ownership: Private
Development stage: Other

Overview

Shanghai GM BioX is a biotechnology company based in Shanghai, China, focused on the discovery and development of innovative therapeutics for oncology and metabolic diseases. The company leverages its expertise in molecular biology and drug discovery to advance a pipeline of small molecule and antibody-based candidates. While currently in the pre-clinical stage, Shanghai GM BioX aims to address significant unmet medical needs through targeted therapeutic approaches. The company is part of the growing biotech ecosystem in the Zhangjiang Hi-Tech Park, benefiting from local research collaborations and infrastructure.

Therapeutic areas: OncologyMetabolic Disorders
Modalities: Small moleculeAntibody
Industry: Biotech

Beyond the preview

Go deeper on Shanghai GM BioX.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shanghai GM BioX.

Explore the full profile